| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.08▲ | 2.08▲ | 2.07▲ | 2.18▼ | 2.15▼ |
| MA10 | 2.08▲ | 2.07▲ | 2.09▲ | 2.19▼ | 2.37▼ |
| MA20 | 2.07▲ | 2.09▼ | 2.15▼ | 2.19▼ | 2.33▼ |
| MA50 | 2.09▼ | 2.17▼ | 2.19▼ | 2.47▼ | 2.05▲ |
| MA100 | 2.16▼ | 2.19▼ | 2.18▼ | 2.32▼ | 2.62▼ |
| MA200 | 2.19▼ | 2.20▼ | 2.33▼ | 2.12▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.007▲ | -0.005▼ | 0.006▲ | -0.058▼ |
| RSI | 54.853▲ | 44.282▼ | 40.506▼ | 41.876▼ | 46.002▼ |
| STOCH | 65.476 | 78.205 | 29.886 | 44.726 | 14.895▼ |
| WILL %R | -14.286▲ | -33.333 | -62.500 | -66.667 | -89.516▼ |
| CCI | 84.756 | 61.947 | -33.333 | -127.109▼ | -96.761 |
|
Thursday, September 11, 2025 01:15 PM
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could ...
|
|
Monday, September 08, 2025 01:17 PM
Immix Biopharma, Inc. (“Immix”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced ...
|
|
Sunday, August 31, 2025 10:38 AM
Among specialty and limited releases, The Toxic Avenger Unrated scared up $1.76 million from 1,995 theaters, while IMAX’s ( NYSE: IMAX) exclusive presentation of Prince – Sign O’ the Times generated ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/09/25 | 2.10 | 2.10 | 2.03 | 2.09 | 199,229 |
| 12/09/25 | 2.22 | 2.22 | 2.10 | 2.10 | 184,883 |
| 11/09/25 | 2.20 | 2.3047 | 2.15 | 2.22 | 124,323 |
| 10/09/25 | 2.26 | 2.3273 | 2.175 | 2.19 | 63,577 |
| 09/09/25 | 2.22 | 2.34 | 2.19 | 2.28 | 182,518 |
| 08/09/25 | 2.19 | 2.21 | 2.0894 | 2.17 | 140,696 |
| 05/09/25 | 2.20 | 2.29 | 2.11 | 2.15 | 199,247 |
| 04/09/25 | 2.21 | 2.24 | 2.16 | 2.19 | 79,893 |
| 03/09/25 | 2.28 | 2.34 | 2.18 | 2.22 | 59,917 |
| 02/09/25 | 2.21 | 2.31 | 2.1609 | 2.28 | 76,071 |
|
|
||||
|
|
||||
|
|